Terms & conditions
Neuron BPh attends the first MAB meeting
Press release 24 Nov 2010 IV ANCES National Awards Neuron BPh has been awarded the first prize for “Business growth of a biotech company”
Federico Mayor Zaragoza becomes a member of the Scientific Advisory Board of Neuron BPh
Neuron BPh is awarded an IDEAL 2009 prize
Neuron BPh and INNOFOOD are set to extract neuroprotective and antioxidant agents from the by-products of fruit such as mangos, custard apples and avocados.
Neuron BPh patents a new compound designed as a potential treatment for Alzheimer’s disease. This is the second molecule developed completely by Spanish scientists at Neuron BPh to combat this disease.
Neuron BPh and Ferrer sign a framework agreement for the future development of joint projects.
Neuron BPh participates in a workshop on the use of zebrafish as a neurophysiological and behavioural model.
Neuron BPh participates in the first workshop on the zebrafish embryo model in toxicology and teratology in Karlsruhe.
Neuron BPh patents a new compound as a potential treatment for Alzheimer’s disease
Neuron BioPharma attends the conference, “Diagnostic tools for the validation of new innovative functional foods: business opportunities” organised by the Spanish Association of Companies for Biotechnological Development (AFBIA).
Neuron BioPharma will attend a conference on luminescence sponsored by the Promega Corporation.